Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (3)
  • 2022 (1)
  • 2021 (1)
  • 2017 (2)

Subject

  • Drug Trafficking (40)
  • Synthetic drugs (20)
  • Arrests/Convictions - Major (18)
  • Overdose (18)
  • Fake Pills (11)
  • Seizures (Drugs/Property) (11)
  • Fentanyl Awareness (10)
  • Prescription Drugs (9)
  • Guns/Weapons (6)
  • Guilty Plea (4)
  • One Pill Can Kill (4)
  • Outreach/Drug Prevention (4)
  • Diversion Division (3)
  • Major Law Enforcement Operation (3)
  • Narcoterrorism (3)
  • Take Back Day (3)
  • International/Foreign Operations (2)
  • Money Laundering (2)
  • OCDETF/Task Force (2)
  • Fentanyl Free America (1)
  • Other (1)
  • Press Conferences (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (4)
  • HIDTA (3)

Drug Name

  • Cocaine (1)
  • Fentanyl (1)

Field Division

  • Washington, DC (44)
  • New Jersey (38)
  • St. Louis (32)
  • New England (30)
  • Chicago (26)
  • New York (22)
  • Miami (21)
  • Seattle (20)
  • Atlanta (13)
  • El Paso (11)
  • Dallas (10)
  • Headquarters (10)
  • Houston (8)
  • San Francisco (8)
  • Louisville (5)
  • Rocky Mountain (5)
  • San Diego (5)
  • New Orleans (4)
  • Omaha (4)
  • Phoenix (3)
  • Philadelphia (1)
  • Los Angeles (7)
Clear All Results
PRESS RELEASE

China-Based Chemical Company, Its Director and Senior Employees Indicted for Alleged Fentanyl Manufacturing and Distribution

November 08, 2024
LOS ANGELES – A chemical company, its director and three senior employees have been charged in a 13-count federal grand jury indictment alleging they sold deadly fentanyl precursor chemicals and xylazine – known as “tranq” – globally, fueling the fentanyl crisis in the United States, the Justice Department announced today...
November 08, 2024
PRESS RELEASE

16 Defendants Charged in Superseding Indictment Alleging Bulk Shipments of Cocaine to Canada, Four Murders

October 21, 2024
LOS ANGELES – A Canadian former Olympic snowboarder and 15 other defendants have been charged in a 16-count superseding indictment for allegedly running and participating in a transnational drug trafficking operation that routinely shipped hundreds of kilograms of cocaine, from Colombia, through Mexico and Southern California, to Canada and other...
October 21, 2024
PRESS RELEASE

Five Defendants, Including Two Doctors, Charged in Connection with Actor Matthew Perry's Fatal Overdose Death Last Year

August 19, 2024
LOS ANGELES – A licensed physician and an alleged San Fernando Valley drug dealer were arrested today in connection with the death of actor Matthew Perry, who suffered a fatal ketamine overdose in October 2023. In total, five defendants, including two doctors, have been charged in this matter, according to...
August 19, 2024
PRESS RELEASE

DEA Los Angeles Field Division Makes Historic Seizure of Approximately 1 Million Fentanyl Pills

July 14, 2022
LOS ANGELES - The U.S. Drug Enforcement Administration (DEA) Los Angeles Field Division High Intensity Drug Trafficking Area (HIDTA) Group 48, seized approximately 1 million fake pills containing fentanyl in Inglewood, Calif. earlier this month. This record-breaking bust is the largest seizure of fentanyl pills DEA has made in California...
July 14, 2022
PRESS RELEASE

High Desert Doctor Arrested on Federal Narcotics Charges

August 16, 2021
LOS ANGELES – A High Desert physician remains in federal custody today after his arrest Wednesday on charges of illegally dispensing prescriptions for often-abused controlled substances – including opioid-based medications – during telemedicine sessions with “patients” from across the United States. Dr. Raphael Tomas Malikian, 36, who resides in Llano...
August 16, 2021
PRESS RELEASE

Reno Doctor Sentenced To 10 Years In Prison For Involuntary Manslaughter Of Patient And Unlawful Distribution Of Large Quantities Of Prescription Drugs

November 20, 2017
RENO, Nev. - Dr. Robert Gene Rand, a Reno physician who operated Rand Family Care, was sentenced today to 10 years in prison for involuntary manslaughter of a patient and unlawful distribution of oxycodone. This sentence is the result of an investigation led by the Drug Enforcement Administration. Rand, 54...
November 20, 2017
PRESS RELEASE

Reno Doctor Robert Rand Pleads Guilty To Involuntary Manslaughter Of Patient And Unlawful Distribution Of Nearly 24,000 Oxycodone Pills

July 17, 2017
RENO, N.V. - Local physician Dr. Robert Rand pleaded guilty today to involuntary manslaughter of a patient and unlawful distribution of oxycodone to another patient, announced Acting U.S. Attorney Steven W. Myhre for the District of Nevada. Sentencing is scheduled for Oct. 23, 2017, before U.S. District Judge Miranda Du...
July 17, 2017
Showing 1 - 7 of 7 results
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster